GlassScriptPhysician profile
Chad Arthur Krueger
NPI 1184858185
$135,140.80
in general payments reported to CMS, 2019-2025
17 companies · $69K in 2025
The $69K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $299 · 2021: $8,586 · 2022: $9,744 · 2023: $817 · 2024: $46K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $78K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $12K · Food and Beverage: $5,615 · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $77,675.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,560.00 |
| Travel and Lodging | $11,605.03 |
| Food and Beverage | $5,614.77 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $131,260.71 | 2020-2025 | Journey II, Real Intelligence, Redapt |
| Restor3d, INC. | $2,545.00 | 2024-2025 | |
| Stryker Corporation | $570.09 | 2019-2025 | Mako |
| Zimmer Biomet Holdings, INC. | $163.85 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Davol INC. | $116.53 | 2021 | |
| Depuy Synthes Sales INC. | $103.19 | 2019 | |
| Ferring Pharmaceuticals INC. | $72.00 | 2023-2025 | Euflexxa |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Heraeus Medical, LLC. | $43.50 | 2023-2025 | Palacos |
| Abbvie INC. | $38.85 | 2019 | |
| Kci USA, INC. | $34.44 | 2022 | |
| Baxter Healthcare | $32.58 | 2024 | Tisseel |
| Amgen INC. | $23.97 | 2019 | |
| Medtronic, INC. | $22.82 | 2025 | Intellis Adaptivestim |
| Ethicon US, LLC | $21.97 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $15.77 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Krueger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.